Anti-Acod1 siRNA-loaded lipid nanoparticles for liver cancer treatment
Abstract 241877 Introduction: Recent studies provide substantial evidence supporting Cis-aconitate decarboxylase 1 (Acod1) as a potential target for cancer immunotherapy....
admin
New Non-Invasive Robotic Technology Now Available for Treating Liver Cancer
Oct. 14, 2024 — Hoag, a nonprofit, regional health care delivery system in Orange County, Calif., is now offering a new...
Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises
Findings show care for chronic liver disease patients is falling on non-specialists who need stronger education and support to ensure...
In many cases, liver cancer is preventable; here are steps you can take to reduce the risk
By Dr. Joseph KimUniversity of Kentucky Liver cancer is the sixth leading cause cancer death in the U.S. The most...
Neurology-focused NeuroX will participate in CMS’ GUIDE Program
NeuroX, a neurology-focused online consultation service, and its physician network ATP Partners announced it will participate in the Centers for...
Radiologists issue ‘call to action’ on looming liver disease ‘crisis’
Radiologists on Thursday issued a “call to action” on fatty liver disease, urging the specialty to get more involved in...
